Herbalife Ltd. Announces Record First Quarter 2012 and Raises 2012 Earnings Guidance
- First quarter worldwide volume point growth of 24 percent with increases in each of its six regions compared to the prior year period.
- First quarter EPS of $0.88 increased 24 percent compared to the prior year period adjusted EPS1.
- Raising FY’12 EPS guidance to a range of $3.58 to $3.74.
- Board of directors approved a $0.30 per share quarterly dividend.
LOS ANGELES--(BUSINESS WIRE)-- Herbalife Ltd. (NYSE:HLF) today reported first quarter net sales of $964.2 million, a 21 percent increase driven by a 24 percent increase in volume points compared to the prior year period. For the same period, the company reported net income of $108.2 million, or $0.88 per diluted share, reflecting an increase of 22 percent and 24 percent respectively compared to the adjusted first quarter 2011 net income of $88.7 million and $0.71 per diluted share.
“Our business momentum has continued into 2012, with strong sales performance from each of our six regions,” said Michael O. Johnson, the company’s chairman and CEO. “The financial strength of our business model is once again reflected in our cash flow generation in the quarter.”
For the quarter ended March 31, 2012, the company generated cash flow from operations of $120.4 million, an increase of 11 percent compared to the prior year period, paid dividends of $35.2 million, invested $24.9 million in capital expenditures and repurchased $50.0 million in common shares outstanding under our share repurchase program.
First Quarter Regional Key Metrics2,3
Regional Volume Point and Average Active Sales Leader Metrics
|Volume Points (Mil)||Average Active Sales Leaders|
|Region||1Q'12||Yr/Yr % Chg||1Q'12||Yr/Yr % Chg|
|South & Central America||164.7||32||%||40,614||31||%|
Updated 2012 Guidance
Guidance for fully diluted 2012 EPS is based on the average daily exchange rates of the first two weeks of April 2012.
Based on current business trends the company’s second quarter fiscal 2012 and fiscal 2012 guidance is provided below.
|Three Months Ending||Twelve Months Ending|
June 30, 2012
December 31, 2012
|Volume Point Growth vs 2011||11.5||%||13.5||%||12.0||%||14.0||%|
|Net Sales Growth vs 2011||9.5||%||11.5||%||12.5||%||14.5||%|
|Cap Ex ($ millions)||$||25.0||$||30.0||$||110.0||$||120.0|
|Effective Tax Rate||27.0||%||29.0||%||26.5||%||28.5||%|
Announces Quarterly Dividend
The company reported today that its board of directors has approved a dividend of $0.30 per share to shareholders of record effective May 15, 2012, payable on May 30, 2012.
First Quarter Earnings Conference Call
Herbalife senior management will host an investor conference call to discuss its recent financial results and provide an update on current business trends on Tuesday, May 1, 2012 at 8 a.m. PST (11 a.m. EST).
The dial-in number for this conference call for domestic callers is (877) 317-1296 and (706) 634-5671 for international callers (conference ID 66116502). Live audio of the conference call will be simultaneously webcast in the investor relations section of the company's website at http://ir.herbalife.com.
An audio replay will be available following the completion of the conference call in MP3 format or by dialing (855) 859-2056 for domestic callers or (404) 537-3406 for international callers (conference ID 66116502). The webcast of the teleconference will be archived and available on Herbalife's website.
About Herbalife Ltd.
Herbalife Ltd. (NYSE:HLF) is a global nutrition company that sells weight-management, nutrition, and personal care products intended to support a healthy lifestyle. Herbalife products are sold in 81 countries through a network of independent distributors. The company supports the Herbalife Family Foundation and its Casa Herbalife program to help bring good nutrition to children. Herbalife's website contains information about Herbalife, including financial and other information for investors at http://ir.Herbalife.com. The company encourages investors to visit its website from time to time, as information is updated and new information is posted.
This document contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements concerning proposed new services or developments; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing. Forward-looking statements may include the words “may,” “will,” “estimate,” “intend,” “continue,” “believe,” “expect” or “anticipate” and any other similar words.
Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, such as those disclosed or incorporated by reference in our filings with the Securities and Exchange Commission. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in our forward-looking statements include, among others, the following:
• any collateral impact resulting from the ongoing worldwide financial “crisis,” including the availability of liquidity to us, our customers and our suppliers or the willingness of our customers to purchase products in a difficult economic environment;
• our relationship with, and our ability to influence the actions of, our distributors;
• improper action by our employees or distributors in violation of applicable law;
• adverse publicity associated with our products or network marketing organization;
• changing consumer preferences and demands;
• our reliance upon, or the loss or departure of any member of, our senior management team which could negatively impact our distributor relations and operating results;
• the competitive nature of our business;
• regulatory matters governing our products, including potential governmental or regulatory actions concerning the safety or efficacy of our products and network marketing program, including the direct selling market in which we operate;
• legal challenges to our network marketing program;
• risks associated with operating internationally and the effect of economic factors, including foreign exchange, inflation, disruptions or conflicts with our third party importers, pricing and currency devaluation risks, especially in countries such as Venezuela;
• uncertainties relating to the application of transfer pricing, duties, value added taxes, and other tax regulations, and changes thereto;
• uncertainties relating to interpretation and enforcement of legislation in China governing direct selling;
• our inability to obtain the necessary licenses to expand our direct selling business in China;
• adverse changes in the Chinese economy, Chinese legal system or Chinese governmental policies;
• our dependence on increased penetration of existing markets;
• contractual limitations on our ability to expand our business;
• our reliance on our information technology infrastructure and outside manufacturers;
• the sufficiency of trademarks and other intellectual property rights;
• product concentration;
• changes in tax laws, treaties or regulations, or their interpretation;
• taxation relating to our distributors;
• product liability claims; and
• whether we will purchase any of our shares in the open markets or otherwise.
We do not undertake any obligation to update or release any revisions to any forward-looking statements or to report any events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.
1 See Schedule A – “Reconciliation of Non-GAAP Financial Measures” for more detail.
2 Supplemental tables that include additional business metrics can be found at http://www.ir.herbalife.com.
3 Worldwide Average Active Sales Leaders may not equal the sum of the Average Active Sales Leaders in each region due to the calculation being an average of Sales Leaders active in a period, not a summation, and the fact that some sales leaders are active in more than one region but are counted only once in the worldwide amount.
RESULTS OF OPERATIONS:
|Condensed Consolidated Statements of Income|
|(In thousands, except per share amounts)|
|South and Central America||165,470||125,277|
|Worldwide net sales||964,175||795,096|
|Cost of Sales||196,144||162,793|
|Interest Expense - net||1,373||2,648|
|Income before income taxes||152,732||120,752|
|Dividends declared per share||$||0.30||$||0.13|
|Condensed Consolidated Balance Sheets|
|Cash & cash equivalents||$||305,861||$||258,775|
|Prepaid expenses and other current assets||127,181||117,073|
|Deferred income taxes||54,754||55,615|
|Total Current Assets||844,984||768,819|
|Property, plant and equipment, net||201,380||193,703|
|Deferred compensation plan assets||23,063||20,511|
|Deferred financing cost, net||4,516||4,797|
|Marketing related intangibles and other intangible assets, net||311,592||311,764|
|LIABILITIES AND SHAREHOLDERS' EQUITY|
|Current portion of long term debt||3,733||1,542|
|Advance sales deposits||41,589||31,702|
|Income taxes payable||30,912||31,415|
|Total Current Liabilities||565,836||548,689|
|Long-term debt, net of current portion||228,055||202,079|
|Deferred compensation plan liability||27,133||23,702|
|Deferred income taxes||68,953||72,348|
|Other non-current liabilities||37,665||39,203|
|Commitments and Contingencies|
|Additional paid in capital||302,310||291,950|
|Accumulated other comprehensive loss||(28,312||)||(37,809||)|
|Total Shareholders' Equity||604,764||560,188|
|Total Liabilities and Shareholders' Equity||$||1,532,406||$||1,446,209|
|Condensed Consolidated Statements of Cash Flows|
|CASH FLOWS FROM OPERATING ACTIVITIES|
|Adjustments to reconcile net income to net cash provided by operating activities:|
|Depreciation and amortization||18,590||18,562|
|Excess tax benefits from share-based payment arrangements||(20,675||)||(6,343||)|
|Share based compensation expenses||7,227||5,604|
|Amortization of discount and deferred financing costs||286||149|
|Deferred income taxes||(597||)||470|
|Unrealized foreign exchange transaction loss (gain)||(3,868||)||1,383|
|Write-off of deferred financing costs||-||914|
|Changes in operating assets and liabilities:|
|Prepaid expenses and other current assets||(4,029||)||(13,582||)|
|Accrued expenses and accrued compensation||(17,373||)||(21,122||)|
|Advance sales deposits||9,062||20,998|
|Deferred compensation plan liability||3,431||3,030|
|NET CASH PROVIDED BY OPERATING ACTIVITIES||120,368||107,968|
|CASH FLOWS FROM INVESTING ACTIVITIES|
|Purchases of property, plant and equipment||(24,691||)||(28,325||)|
|Proceeds from sale of property, plant and equipment||15||2|
|Deferred compensation plan assets||(2,552||)||(197||)|
|NET CASH USED IN INVESTING ACTIVITIES||(27,228||)||(28,520||)|
|CASH FLOWS FROM FINANCING ACTIVITIES|
|Borrowings from long-term debt||114,560||289,700|
|Principal payments on long-term debt||(86,402||)||(284,924||)|
|Deferred financing costs||-||(5,516||)|
|Excess tax benefits from share-based payment arrangements||20,675||6,343|
|Proceeds from exercise of stock options and sale of stock under employee stock purchase plan||7,128||1,689|
|NET CASH USED IN FINANCING ACTIVITIES||(52,153||)||(16,492||)|
|EFFECT OF EXCHANGE RATE CHANGES ON CASH||6,099||7,260|
|NET CHANGE IN CASH AND CASH EQUIVALENTS||47,086||70,216|
|CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR||258,775||190,550|
|CASH AND CASH EQUIVALENTS, END OF YEAR||305,861||260,766|
|CASH PAID DURING THE YEAR|
|Income taxes paid||$||29,958||$||21,874|
SCHEDULE A: RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
(unaudited), (Dollars in Thousand, Except Per Share Data)
In addition to its reported results, the Company has included in the tables below adjusted results that the Securities and Exchange Commission defines as “non-GAAP financial measures.” Management believes that such non-GAAP financial measures, when read in conjunction with the Company’s reported results, can provide useful supplemental information for investors in analyzing period to period comparisons of the Company’s results. However, non-GAAP financial measures should not be considered substitute for, nor superior to, financial results and measures determined or calculated in accordance with GAAP.
|The following is a reconciliation of net income, presented and reported in accordance with U.S. generally accepted accounting principles, to net income adjusted for certain items:|
|Three Months Ended|
|Net income, as reported||$||108,162||$||88,019|
|Write-off of unamortized deferred financing cost|
|from debt refinancing (net of $214 tax benefit)||-||700|
|Net income, as adjusted||$||108,162||$||88,719|
|The following is a reconciliation of diluted earnings per share, presented and reported in accordance with U.S. generally accepted accounting principles, to diluted earnings per share adjusted for certain items:|
|Three Months Ended|
|Diluted earnings per share, as reported||$||0.88||$||0.70|
|Write-off of unamortized deferred financing cost|
|from debt refinancing||-||0.01|
|Diluted earnings per share, as adjusted||$||0.88||$||0.71|
The following is a reconciliation of total long-term debt to net debt:
|Total long-term debt (current and long-term portion)||$||231,788||$||203,621|
|Less: Cash and cash equivalents||305,861||258,775|
SVP, Worldwide Corp. Comm.
VP, Investor Relations
Source: Herbalife Ltd.
Released Apr 30, 2012 • 4:15pm EDT